Find a Pediatric Clinical Trial

Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our list of clinical trials that are currently enrolling new pediatric patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

Showing 41 - 60 of 91 trials
Titlesort icon Investigator Disease(s)
A Phase II Study of Temozolomide plus Irinotecan with or without Bevacizumab in Children with Recurrent or Refractory Medulloblastoma or PNET
[Protocol 11-089]
De Braganca, Kevin
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase II Study of Sunitinib to Treat High-Grade Glioma and Ependymoma Tumors in Pediatric and Young Adult Patients
[Protocol 13-026]
Khakoo, Yasmin
  • Brain Tumors, Primary
    • Gliomas
    • Other Trials
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase II Study of Sorafenib in Children and Young Adults with Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, or Papillary Thyroid Cancer
[Protocol 12-139]
Trippett, Tanya
  • Hepatobiliary
    • Liver Cancer
  • Kidney Cancer
  • Sarcomas
    • Rhabdomyosarcoma
  • Thyroid Cancer
A Phase II Study of Response-Based Radiation Therapy for Patients with Localized Germ Cell Tumors of the Central Nervous System
[Protocol 12-243]
Dunkel, Ira
  • Germ Cell Tumors
  • Pediatric Brain Tumors
    • CNS Cancer
A Phase II Study of Peri-transplant Palifermin followed by an Allogeneic T-Cell-Depleted Stem Cell Transplant in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved from MDS
[Protocol 08-008]
Castro-Malaspina, Hugo
  • Blood & Marrow Stem Cell Transplantation
    • Sibling and Unrelated Volunteer
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelogenous Leukemia
A Phase II Study of New Treatment Approaches for High-Risk Renal Tumors
[Protocol 12-026]
Kobos, Rachel
  • Kidney Cancer
  • Sarcomas
A Phase II Study of Irinotecan and Temozolomide in Combination with Existing High-Dose Chemotherapy for Patients Newly Diagnosed with Ewing Sarcoma
[Protocol 13-068]
Magnan, Heather
  • Sarcomas
    • Ewing's Sarcoma
    • Soft Tissue Sarcoma
A Phase II Study of Ipilimumab in Children and Adolescents with Stage III/IV Inoperable Melanoma
[Protocol 13-043]
Dunkel, Ira
  • Melanoma
A Phase II Study of Intrathecal I131-3F8 in Patients with GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms
[Protocol 05-122]
Kramer, Kim
  • Brain Tumors, Metastatic
  • Brain Tumors, Primary
    • Brain Metastases
  • Neuroblastoma
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Phase II Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma
[Protocol 12-205]
Chou, Alexander
  • Primary Bone
    • Osteosarcoma
  • Sarcomas
    • Osteosarcoma
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in the Bone Marrow
[Protocol 09-161]
Kushner, Brian
  • Neuroblastoma
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma
[Protocol 09-160]
Kushner, Brian
  • Neuroblastoma
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission after Non-Myeloablative Therapy in Patients with High-Risk Neuroblastoma
[Protocol 09-159]
Kushner, Brian
  • Neuroblastoma
A Phase II Study of Everolimus, Leuprolide/Letrozole, and Everolimus/Leuprolide/Letrozole in Patients with Inoperable Fibrolamellar Hepatocellular Carcinoma
[Protocol 11-211]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase II Study of Dasatinib in Children and Adolescents Newly Diagnosed with Chronic Phase CML or with Philadelphia Chromosome-Positive Leukemias Resistant to or Intolerant of Imatinib
[Protocol 11-030]
Shukla, Neerav
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Chronic Myelocytic Leukemia
A Phase II Study of Cyclophosphamide, Topotecan, and Bevacizumab in Patients with Relapsed or Refractory Ewing's Sarcoma and Neuroblastoma
[Protocol 11-183]
Trippett, Tanya
  • Neuroblastoma
  • Primary Bone
    • Ewing's Sarcoma
  • Sarcomas
    • Ewing's Sarcoma
    • Soft Tissue Sarcoma
A Phase II Study of CMV-Immune T cells for the Treatment of Cytomegalovirus Infection after Stem Cell Transplantation
[Protocol 12-086]
O'Reilly, Richard
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
A Phase II Study of Cixutumumab plus Temsirolimus in Children with Recurrent or Refractory Sarcoma
[Protocol 12-188]
Wexler, Leonard
  • Primary Bone
    • Osteosarcoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
A Phase II Study of Bulk Versus Fractionated Stem Cell Infusions in Patients with Hematologic Cancers Undergoing Stem Cell Transplantation
[Protocol 12-016]
Giralt, Sergio
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Multiple Myeloma
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase II Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
[Protocol 12-035]
Horwitz, Steven
  • Lymphoma
    • Non-Hodgkin's Lymphoma